|
RRAGA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.351100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.23839999996733E-06 |
| Normal-vs-Stage2 |
1.967630E-01 |
| Normal-vs-Stage3 |
5.126200E-02 |
| Normal-vs-Stage4 |
2.029000E-01 |
| Stage1-vs-Stage2 |
1.310590E-01 |
| Stage1-vs-Stage3 |
1.075180E-01 |
| Stage1-vs-Stage4 |
1.110580E-01 |
| Stage2-vs-Stage3 |
8.268000E-01 |
| Stage2-vs-Stage4 |
9.496400E-01 |
| Stage3-vs-Stage4 |
7.552200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.587000E-04 |
| Normal-vs-AfricanAmerican |
1.490080E-02 |
| Normal-vs-Asian |
3.422800E-01 |
| Caucasian-vs-AfricanAmerican |
6.275200E-01 |
| Caucasian-vs-Asian |
5.609600E-01 |
| AfricanAmerican-vs-Asian |
4.154200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.018000E-02 |
| Normal-vs-Female |
8.03029998053262E-09 |
| Male-vs-Female |
4.20540000045655E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.921030E-01 |
| Normal-vs-Age(41-60Yrs) |
5.183800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.582400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.865590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.134000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.991600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.971800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.049200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.714600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.579800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.245170E-04 |
| Normal-vs-Grade 2 |
7.4253999948759E-08 |
| Normal-vs-Grade 3 |
1.759800E-02 |
| Normal-vs-Grade 4 |
5.884200E-01 |
| Grade 1-vs-Grade 2 |
4.182000E-01 |
| Grade 1-vs-Grade 3 |
9.005900E-02 |
| Grade 1-vs-Grade 4 |
1.031990E-02 |
| Grade 2-vs-Grade 3 |
5.082500E-03 |
| Grade 2-vs-Grade 4 |
1.59754999999873E-05 |
| Grade 3-vs-Grade 4 |
2.640300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.49520396064418E-11 |
| Normal-vs-ccB subtype |
4.542000E-01 |
| ccA subtype-vs-ccB subtype |
1.52322598978571E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.622400E-04 |
| Normal-vs-N1 |
7.132800E-01 |
| N0-vs-N1 |
9.773900E-02 |
|
|
